Last quarter (Q4 2023), Tarsus Pharmaceuticals's total revenue was $13.08M, an increase of 30.76% from the same quarter last year. In Q4, Tarsus Pharmaceuticals's net income was $-41.90M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 17.45M	$ 17.45M	$ 25.82M	$ 57.03M	$ 0.00	$ 0.00
Cost of Revenue	$ 1.59M	$ 1.59M	$ -955.00K	$ -2.08M	$ 0.00	-
Gross Profit	$ 15.85M	$ 15.85M	$ 24.36M	$ 54.95M	$ 0.00	-
Operating Expense	$ 160.60M	$ 160.60M	$ -88.53M	$ -69.18M	$ 27.00M	$ 4.30M
Operating Income	$ -143.16M	$ -143.16M	$ -63.21M	$ -12.16M	$ -27.00M	$ -4.30M
Net Non Operating Interest Income Expense	$ 7.01M	$ 6.99M	$ 1.30M	$ 36.00K	$ 188.00K	$ -40.00K
Other Income Expense	$ -273.00K	$ -274.00K	$ 182.00K	$ 664.00K	-	$ -331.00K
Pretax Income	$ -135.89M	$ -135.89M	$ -62.09M	$ -13.77M	$ -26.81M	$ -4.67M
Tax Provision	$ -4.40M	$ -4.40M	$ -4.00K	$ 55.00K	$ 1.00K	$ 1.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -135.89M	$ -135.89M	$ -62.09M	$ -12.84M	$ -26.81M	$ -4.67M
Basic EPS	$ -4.59	$ -4.62	$ -2.52	$ -0.67	$ -4.32	$ -1.09
Diluted EPS	$ -4.59	$ -4.62	$ -2.52	$ -0.67	$ -4.32	$ -1.09
Basic Average Shares	$ 117.53M	$ 29.38M	$ 24.62M	$ 20.55M	$ 6.21M	$ 4.29M
Diluted Average Shares	$ 117.53M	$ 29.38M	$ 24.62M	$ 20.55M	$ 6.21M	$ 4.29M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 162.20M	$ 162.20M	$ -89.48M	$ -71.26M	$ 27.00M	$ 4.30M
Net Income From Continuing And Discontinued Operation	$ -135.89M	$ -135.89M	$ -62.09M	$ -12.84M	$ -26.81M	$ -4.67M
Normalized Income	$ -102.06M	$ -140.30M	-	-	$ -26.81M	$ -4.43M
Interest Expense	-	-	-	-	-	-
EBIT	$ -132.48M	$ -129.59M	$ -61.79M	$ -13.81M	$ -27.00M	$ -4.30M
EBITDA	$ -96.17M	$ -130.95M	$ -62.00M	$ -13.20M	$ -26.90M	$ -4.26M

Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing